ClearPoint Neuro Inc.
Last updated September 27, 2026
Organization details
- Legal name
- ClearPoint Neuro Inc.
- Former names
- MRI Interventions, INC. Surgivision Inc Surgi Vision Inc
- Ownership
- Public
- Status
- Active
- SIC code
- 3841 — Surgical & Medical Instruments & Apparatus
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Solana Beach
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- CLPT
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001285550
- EIN
- 58-2394628
Board of directors
-
B. Kristine Johnson · DirectorSince 2023
-
Joseph Michael Burnett · Director · CEO and PresidentSince 2023
-
Linda M. Liau · DirectorSince 2023
-
Lynnette C. Fallon · DirectorSince 2023
-
Matthew B. Klein · DirectorSince 2023
-
Pascal E. R. Girin · DirectorSince 2023
-
R. John Fletcher · DirectorSince 2023
-
Timothy T. Richards · DirectorSince 2023
Chief executives
Joseph Michael Burnett
· CEO and President
Dates unknown
Director election results
Annual meeting of May 20, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
97.9%
-
98.2%
-
98.2%
-
98.3%
-
98.3%
-
98.7%
-
98.8%
Board connections
3 of this board's directors also sit on 3 other boards.
- via B. Kristine Johnson
- via R. John Fletcher
- via Matthew B. Klein
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $3,181,017
- 13 sales by 4 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 2, 2026 | Joseph Michael Burnett Director, Officer (CEO and President) | Option exercise | +12,517 | $3.47 | $43,434 |
| Jul 1, 2026 | Timothy T. Richards Director | Grant or award | +222 | $17.84 | $3,960 |
| Jul 1, 2026 | R. John Fletcher Director | Grant or award | +662 | $17.84 | $11,810 |
| Jun 30, 2026 | Joseph Michael Burnett Director, Officer (CEO and President) | Grant or award | +1,361 | $11.93 | $16,237 |
| Jun 30, 2026 | D'Alessandro Danilo Officer (Chief Financial Officer) | Grant or award | +1,085 | $11.93 | $12,944 |
| Jun 30, 2026 | STIGALL L. JEREMY Officer (Chief Business Officer) | Grant or award | +1,781 | $11.93 | $21,247 |
| Jun 29, 2026 | Joseph Michael Burnett Director, Officer (CEO and President) | Option exercise | +20,000 | $2.50 | $50,000 |
| Jun 29, 2026 | Joseph Michael Burnett Director, Officer (CEO and President) | Open-market sale | −20,000 | $19.38 | $387,600 |
| Jun 17, 2026 | Joseph Michael Burnett Director, Officer (CEO and President) | Option exercise | +60,000 | $2.50 | $150,000 |
| Jun 17, 2026 | Joseph Michael Burnett Director, Officer (CEO and President) | Open-market sale | −60,000 | $17.79 | $1,067,400 |
| Jun 17, 2026 | Joseph Michael Burnett Director, Officer (CEO and President) | Open-market sale | −1,843 | $17.94 | $33,063 |
| Jun 4, 2026 | Timothy T. Richards Director | Option exercise | +500 | $10.00 | $5,000 |
| Jun 4, 2026 | Timothy T. Richards Director | Shares withheld for tax | −376 | $13.30 | $5,001 |
| Jun 1, 2026 | Timothy T. Richards Director | Open-market sale | −5,415 | $12.17 | $65,901 |
| May 21, 2026 | Matthew B. Klein Director | Open-market sale | −16,000 | $11.59 | $185,440 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.